Neurocrine Biosciences, Inc.

AMORNAY

Pharmaceutical preparations for the treatment of sleep disorders, insomnia;

APRIENT

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, insomnia, endometriosis, uterine fibroids, tardive dyskinesia, Tourette syndrome, muscle dystonia, neurological-related movement disorders and involuntary tics resulting from neurological disorders;The wording Aprient has no meaning in a foreign language.;

AURIZON

pharmaceutical preparations for the treatment of insomnia;

AZUNEDE

Pharmaceutical preparations for the treatment of sleep disorders, insomnia;

AZURTRA

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders, insomnia, endometriosis, uterine fibroids, tardive dyskinesia, Tourette syndrome, dystonia, movement disorders, tics;

BARDYSA

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders, insomnia, endometriosis, uterine fibroids, tardive dyskinesia, Tourette syndrome, dystonia, movement disorders, tics;

CAHTALOG

Educational services namely, providing online seminars, webinars, lectures, conferences and colloquia in the field of congenital adrenal hyperplasia; Providing an in-person educational forum in the field of congenital adrenal hyperplasia; Educational services, namely providing seminars, webinars, workshops, conferences and colloquia in the field of congenital adrenal hyperplasia; Providing online non-downloadable electronic publications in the nature of brochures, workbooks, newsletters, journals, report, flyers and pamphlets in the field of congenital adrenal hyperplasia; Providing online non-downloadable electronic publications, namely newsletters, articles, studies, reports, journals, magazines, blog posts and pamphlets in the field of congenital adrenal hyperplasia medical research; Providing online non-downloadable electronic training materials in the nature of user manuals in the field of congenital adrenal hyperplasia;Downloadable software to enable users to provide and review patient health information and access a patient health registry; downloadable electronic publications in the nature of brochures, workbooks, newsletters, journals, report, flyers and pamphlets in the field of congenital adrenal hyperplasia; Downloadable electronic publications, namely newsletters, articles, studies, reports, journals and pamphlets in the field of congenital adrenal hyperplasia medical research; downloadable software app to enable users to access a patient health registry; Downloadable electronic training materials in the nature of user manuals in the field of congenital adrenal hyperplasia;Printed publications in the nature of brochures, workbooks, newsletters, journals, reports, flyers and pamphlets in the field of congenital adrenal hyperplasia; Printed publications, namely newsletters, articles, studies, reports, journals, magazines and pamphlets in the field of congenital adrenal hyperplasia medical research; Printed training materials in the nature of user manuals in the field of congenital adrenal hyperplasia;CATALOG;Promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; Updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia;Providing medical information; providing a website featuring a registry of patients with congenital adrenal hyperplasia for medical treatment purposes; providing medical and health information to consumers, patients, doctors, and caregivers in the field of congenital adrenal hyperplasia;Medical and scientific research services; providing an online computer database that contains data on clinical outcomes, patient-reported outcomes, clinician-reported outcomes, caregiver outcomes and health care resource utilization for medical and scientific research purposes; providing information in the field of medical and scientific research featuring a registry of patients with congenital adrenal hyperplasia; administering a scientific advisory committee in the nature of providing scientific advice and scientific consultation relating to congenital adrenal hyperplasia; hosting an online community website featuring shared communications between community members in the field of congenital adrenal hyperplasia; providing an online community for users to engage with and share information in the field of congenital adrenal hyperplasia; computer services, namely, creating an online community for registered users to participate in discussions, get feedback from their peers, form virtual communities, and engage in social networking services in the field of congenital adrenal hyperplasia; creating an on-line community for doctors, patients, clinicians and caregivers for the purpose of participating in discussions about congenital adrenal hyperplasia;

CAHTALYST

CATALYST;Providing medical information; excluding medical information in the field of ophthalmology;Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; all of the foregoing excluding use in the field of ophthalmology;

CAHTALYST

The mark consists of the word CAHtalyst in yellow to the right of a yellow circle with white and blue arches inside of it.;CATALYST;The color(s) yellow white and blue is/are claimed as a feature of the mark.;Providing medical information; excluding medical information in the field of ophthalmology;Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; all of the foregoing excluding use in the field of ophthalmology;